-
1
Surveillance of Adverse Events Following Varicella Vaccine Immunization in Zhejiang Province, China, from 2020 to 2022
Published 2025-01-01Subjects: “…varicella vaccine…”
Get full text
Article -
2
Immunogenicity and safety of a live attenuated varicella vaccine in healthy subjects aged between 13 to 55 years: a double-blind, randomized, active-controlled phase iii clinical t...
Published 2025-12-01Subjects: “…Varicella vaccine…”
Get full text
Article -
3
Immunogenicity and safety of a live attenuated varicella vaccine in children aged 1 to 12 years: A double-blind, randomized, parallel-controlled phase III clinical trial in China
Published 2025-12-01Subjects: “…Varicella vaccine…”
Get full text
Article -
4
Effectiveness of a 2-dose varicella vaccination program in Changzhou, China, during the transitional period (2017–2022): a registry-based case-cohort study
Published 2025-01-01Subjects: “…Varicella Vaccine (VarV)…”
Get full text
Article